0001209191-23-003997.txt : 20230119
0001209191-23-003997.hdr.sgml : 20230119
20230119160547
ACCESSION NUMBER: 0001209191-23-003997
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230117
FILED AS OF DATE: 20230119
DATE AS OF CHANGE: 20230119
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Allen Patricia L
CENTRAL INDEX KEY: 0001348587
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38219
FILM NUMBER: 23537481
BUSINESS ADDRESS:
BUSINESS PHONE: 978-687-6988
MAIL ADDRESS:
STREET 1: C/O DECIPHERA PHARMACEUTICALS, INC
STREET 2: 200 SMITH STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Deciphera Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001654151
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200299725
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 SMITH STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-209-6400
MAIL ADDRESS:
STREET 1: 200 SMITH STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
FORMER COMPANY:
FORMER CONFORMED NAME: Deciphera Pharmaceuticals, LLC
DATE OF NAME CHANGE: 20150928
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-01-17
0
0001654151
Deciphera Pharmaceuticals, Inc.
DCPH
0001348587
Allen Patricia L
C/O DECIPHERA PHARMACEUTICALS, INC.
200 SMITH STREET
WALTHAM
MA
02451
1
0
0
0
Stock Option (Right to Buy)
21.27
2023-01-17
4
A
0
3269
15.2952
A
2033-01-16
Common Stock
3269
3269
D
These options were issued upon election by the director to receive her cash board retainer fee of $50,000 for the FY 2023 in the form of an equity award, in lieu of cash, under the amended and restated non-employee director compensation policy. The shares will vest in four substantially equal installments on each of March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023.
/s/ Jeffrey M. Held, Attorney-in-Fact
2023-01-19